NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues rose 12 percent year over year, driven by an 8 percent increase in tests delivered during the quarter.

For the three months ended Sept. 30, the molecular diagnostics firm reported total revenues of $82.3 million, compared to $73.6 million in the year-ago quarter. This fell slightly short of the consensus Wall Street estimate of $83.2 million for Q3 2016.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.